Scott M. Rocklage, 10% Owner at Skye Bioscience, Inc. (SKYE), sold 454,026 shares at $3.57 ($1.6M) on 2025-08-21, disclosed to the SEC on 2025-08-22.
Open-market sale of $1.6M SKYE by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.57 | 2,314 | $8K | 0.5% |
| 2 | $3.57 | 58,642 | $209K | 13.3% |
| 3 | $3.57 | 58,642 | $209K | 13.3% |
| 4 | $3.42 | 6,470 | $22K | 1.4% |
| 5 | $3.42 | 163,979 | $561K | 35.7% |
| 6 | $3.42 | 163,979 |
| $561K |
| 35.7% |
| Total | $3.46 avg | 454,026 | $1.6M | 100% |
| Filing → |
| APRE | SELL | 2020-06-15 | $7.0M | — | Filing → |
| APRE | SELL | 2020-05-21 | $9.0M | — | Filing → |
| CRNX | SELL | 2019-06-25 | $5.5M | — | Filing → |